NCT00356408 Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's Disease Status COMPLETED Phase PHASE3
NCT00353756 Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease Status UNKNOWN Phase PHASE1
NCT00349752 Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease Status TERMINATED Phase PHASE3
NCT00348283 Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon Status COMPLETED Phase PHASE3
NCT00338650 Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE) Status COMPLETED Phase PHASE3
NCT00333788 Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease Status COMPLETED Phase PHASE3
NCT00329550 Maintenance Study of Certolizumab Pegol (CZP) in Crohn's Disease Status COMPLETED Phase PHASE2
NCT00329537 Study of Sargramostim in Moderately to Severely Active Crohn's Disease Status TERMINATED Phase PHASE2
NCT00329420 Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668) Status COMPLETED Phase PHASE2
NCT00308581 Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab Status COMPLETED Phase PHASE3
NCT00308438 Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008 Status COMPLETED Phase PHASE2
NCT00307931 Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab Status TERMINATED Phase PHASE3
NCT00306215 A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE2
NCT00304252 Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease Status TERMINATED Phase PHASE2
NCT00300118 Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD) Status COMPLETED Phase PHASE3
NCT00294112 Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease Status COMPLETED Phase PHASE2
NCT00291668 Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease Status COMPLETED Phase PHASE2